WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996005221) CALCITONIN RECEPTOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/005221    International Application No.:    PCT/US1994/009235
Publication Date: 22.02.1996 International Filing Date: 16.08.1994
Chapter 2 Demand Filed:    28.02.1996    
IPC:
A61K 38/00 (2006.01), C07K 14/72 (2006.01)
Applicants: HUMAN GENOME SCIENCES, INC. [US/US]; Suite 300, 9620 Medical Center Drive, Rockville, MD 20850-3338 (US) (For All Designated States Except US).
LI, Yi [CN/US]; (US) (For US Only).
LEE, Norman, H. [US/US]; (US) (For US Only)
Inventors: LI, Yi; (US).
LEE, Norman, H.; (US)
Agent: OLSTEIN, Elliot, M.,; Carella, Byrne, Bain, Gilfillan, Cecchi, Stewart & Olstein, 6 Becker Farm Road, Roseland, NJ 07068 (US)
Priority Data:
Title (EN) CALCITONIN RECEPTOR
(FR) RECEPTEUR DE CALCITONINE
Abstract: front page image
(EN)A human calcitonin receptor polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for identifying antagonists and agonists to such polypeptide. Antagonists against such polypeptides may be used therapeutically to treat hypocalcemia and agonists which may be used to treat hypercalcemia and disorders of bone remodelling.
(FR)Polypeptide récepteur de calcitonine humaine et ADN (ARN) codant ce polypeptide et procédé de production de ce polypeptide par une technique de recombinaison. On décrit également des procédés d'utilisation de ce polypeptide pour l'identification d'antagonistes et d'agonistes de ce polypeptide. On peut utiliser en thérapie lesdits antagonistes pour traiter l'hypocalcémie, et les agonistes pour traiter l'hypercalcémie et les troubles de remodelage osseux.
Designated States: AU, CA, CN, JP, KR, NZ, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)